$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
乐伐替尼单药使用好还是联合其他药物使用好?
2025-10-19 11:44:20
Check Details
乐伐替尼治疗晚期肝细胞癌的2期研究
2025-10-19 11:44:20
Check Details
卡博替尼已成为索拉非尼耐药后的首选靶向药
2025-10-19 11:44:20
Check Details
老年肝癌患者服用索拉非尼的成本效益如何?
2025-10-19 11:44:20
Check Details
数据证明:肝癌患者服用索拉非尼获得的总生存期延长了44%
2025-10-19 11:44:20
Check Details
肝癌患者服用瑞格菲尼之后,反响如何?
2025-10-19 11:44:20
Check Details
瑞格菲尼如何进行服用?
2025-10-19 11:44:20
Check Details
乐伐替尼治疗肝癌疗效显著
2025-10-19 11:44:20
Check Details
卡博替尼称号“万能药”的由来
2025-10-19 11:44:20
Check Details
更长中位生存期的疗效,卡博替尼的功劳无可厚非
2025-10-19 11:44:20
Check Details
多吉美产生耐药的原因是什么?
2025-10-19 11:44:20
Check Details
多吉美针对哪些晚期肝癌不适用?
2025-10-19 11:44:20
Check Details
1
2
...
8613
8614
8615
8616
8617
8618
8619
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
2
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
3
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
4
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
5
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
6
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
7
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
8
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
9
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
10
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
11
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
12
Complete Guide to Dosage and Dose Adjustment of Entrectinib